Skip to main content
. 2021 May 18;11:651380. doi: 10.3389/fonc.2021.651380

Table 2.

Clinical and pathological data of the patients enrolled in tissue and plasma study.

Variable Tissue study (n=28) Plasma study (n=35) P-value Statistical test
Median (range) Median (range)
Age (years) 55.5 (36-84) 60 (19-82) 0.598 Mann-Whitney U test
Body mass index 25.6 (17.3-36.5) 25.7 (18.4-40.4) 0.682 Mann-Whitney U test
n (%) n (%)
Gender
F 12 (42.9%) 13 (37.1%) 0.796 Fischer’s exact test
M 16 (57.1%) 22 (62.9%)
Tumor size
T2 1 (3.6%) 1 (2.9%) 0.0174* Fischer’s exact test
T3 22 (78.6%) 16 (45.7%)
T4 5 (17.9%) 16 (45.7%)
NA 2 (5.7%)
Lymph nodes
N0 3 (10.7%) 6 (17.1%) 0.566 Fischer’s exact test
N1 14 (50.0%) 12 (34.3%)
N2 11 (39.3%) 13 (37.1%)
Nx 4 (11.4%)
Metastasis In evolution Baseline
M-/M0 16 (57.1%) 11 (31.4%)
M+/M1 12 (42.9%) 22 (62.9%)
Mx 2 (5.7%)
Lymphatic invasion
L0 8 (28.6%) 7 (20.0%) 0.999 Fischer’s exact test
L1 18 (64.3%) 15 (42.9%)
Lx 2 (7.1%) 13 (37.1%)
Perineural invasion
P0 16 (57.1%) 11 (31.4%) 0.524 Fischer’s exact test
P1 7 (25.0%) 8 (22.9%)
Px 5 (17.9%) 16 (45.7%)
Grade
G1 5 (17.9%) 4 (11.4%) 0.926 Fischer’s exact test
G2 18 (64.3%) 19 (54.3%)
G3 5 (17.9%) 5 (14.3%)
NA 7 (20.0%)
Stage
S2 3 (10.7%) 4 (11.4%) 0.168 Fischer’s exact test
S3 25 (89.3%) 8 (22.9%)
S4 23 (65.7%)

*p≤0.05.